Literature DB >> 12388201

Baclofen blocks LES relaxation and crural diaphragm inhibition by esophageal and gastric distension in cats.

Jianmin Liu1, Nonko Pehlivanov, Ravinder K Mittal.   

Abstract

Esophageal distension and transient lower esophageal sphincter (LES) relaxation (TLESR) are accompanied by simultaneous relaxation of the LES and inhibition of crural diaphragm. Recent studies indicate that baclofen decreases the frequency of TLESR; however, its effect on the crural diaphragm is not known. We evaluated the effects of baclofen on LES relaxation and crural diaphragm inhibition induced by gastric distension and esophageal distension in cats. Five adult cats underwent surgical implantation of wire electrodes into the crural and costal diaphragm for measurement of their EMG activity, respectively. One week after the surgery, animals were lightly sedated and recordings were performed using a manometry catheter equipped with a 2.5-cm balloon. The effects of baclofen (10 micromol/kg iv) on the graded esophageal distension and gastric distension-induced LES and crural diaphragm responses were studied. Distension of the esophagus and stomach induces relaxation of the LES and inhibition of the crural diaphragm, simultaneously. Baclofen blocks both the esophageal and the gastric distension-induced relaxation of the LES and inhibition of the crural diaphragm. The magnitude of response to baclofen was significantly larger for the crural diaphragm inhibition than for the LES relaxation. Baclofen, a GABA(B) receptor agonist, blocks the reflex inhibitory pathway to the LES and crural diaphragm. The reflex inhibitory pathway to the crural diaphragm is more sensitive to blockade by baclofen than the reflex LES inhibitory pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388201     DOI: 10.1152/ajpgi.00080.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

1.  Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.

Authors:  A Lehmann; M Antonsson; A Aurell-Holmberg; L A Blackshaw; L Brändén; T Elebring; J Jensen; L Kärrberg; J P Mattsson; K Nilsson; S S Oja; P Saransaari; S von Unge
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  The Physiology of Eructation.

Authors:  Ivan M Lang
Journal:  Dysphagia       Date:  2015-12-22       Impact factor: 3.438

3.  Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.

Authors:  Anders Lehmann; Ann Aurell Holmberg; Ulhas Bhatt; Marianne Bremner-Danielsen; Lena Brändén; Susanne Elg; Thomas Elebring; Kevin Fitzpatrick; William B Geiss; Peter Guzzo; Jorgen Jensen; Gunilla Jerndal; Jan P Mattsson; Karolina Nilsson; Britt-Marie Olsson
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  A novel pattern of longitudinal muscle contraction with subthreshold pharyngeal stimulus: a possible mechanism of lower esophageal sphincter relaxation.

Authors:  Eric Leslie; Valmik Bhargava; Ravinder K Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-15       Impact factor: 4.052

Review 5.  Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?

Authors:  James Wise; Jeffrey L Conklin
Journal:  Curr Gastroenterol Rep       Date:  2004-06

Review 6.  Current Advancement on the Dynamic Mechanism of Gastroesophageal Reflux Disease.

Authors:  Zhi Zheng; Yuxi Shang; Ning Wang; Xiaoye Liu; Chenglin Xin; Xiaosheng Yan; Yuhao Zhai; Jie Yin; Jun Zhang; Zhongtao Zhang
Journal:  Int J Biol Sci       Date:  2021-10-03       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.